In June, the red sun burns like fire, brimming over with vigor and vitality. In this wonderful early summer, the results of the “2018 All-Asia Executive Team Honored Companies” survey, organized by the internationally authoritative Magazine——Institutional Investor, were announced. China Medical System Holdings Limited (“CMS” or “the Group”) is recognized as the 2018 “Honored Company” in Health Care and Pharmaceuticals Industry. Besides, Ms. Yanling Chen, the Executive Director, CFO and Vice President of CMS, won the Third Place of 2018 “All-Asia Best CFO (Overall) in Health Care and Pharmaceuticals Industry”. This is the seventh consecutive time for Ms. Yanling Chen being awarded.
The Headquarter of Institutional Investor located in New York, USA. As one of the most influential financial magazines, Institutional Investor has consistently distinguished itself among the world’s foremost media companies. The total number of participants in the “2018 All-Asia Executive Team Honored Companies” survey achieves a new record, with 3,538 buy-side individuals and 982 sell-side analysts.
With precise strategic positioning and international development insight, CMS searches and acquires innovative and high quality drugs from the global market. And through its nationwide professional promotional network, CMS delivers the academic value and medical evidence of drugs to clients. Since listed in HK Stock Exchange, the Group is always adhering to close and sincere communication with its investors and cherish every communication opportunity with the investors, to deliver the information of the Group’s operation and development to domestic and oversea investors and analysts in more transparent, fair and timely ways. The Group will continue to take innovation as its driving force, and academic promotion as the core. We hope to witness the future development of the company together with investors and analysts at home and abroad.
